awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38079578-01C14866-7A23-4B93-ABFC-D84E1478230D
Q38079578-01C14866-7A23-4B93-ABFC-D84E1478230D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38079578-01C14866-7A23-4B93-ABFC-D84E1478230D
Relapsed and refractory lymphoid neoplasms and multiple myeloma with a focus on carfilzomib.
P2860
Q38079578-01C14866-7A23-4B93-ABFC-D84E1478230D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38079578-01C14866-7A23-4B93-ABFC-D84E1478230D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d67adc2c456653a3deb6943e2cccec16b032016f
P2860
The proteasome inhibitors bortezomib and PR-171 have antiproliferative and proapoptotic effects on primary human acute myeloid leukaemia cells.